Completed OBSERVATIONAL NCT03023566

Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI

Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI in Pediatric and Neonatal Patient Population (<18years)

Sponsor: Guerbet

Conditions Brain Diseases

Interventions Dotarem

Updated 9 times since 2017 Last updated: May 18, 2022 Started: Feb 9, 2017 Primary completion: Nov 12, 2017 Completion: Nov 12, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Brain Diseases, this trial is completed. The trial is conducted by Guerbet and has accumulated 9 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2022 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Jan 2021 — Jun 2022 [monthly]

Unknown Status
Apr 2019 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status

▶ Show 4 earlier versions

Jun 2018 — Apr 2019 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Apr 2017 — Apr 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2017 — Apr 2017 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guerbet
Phoenix Children's Hospital

Data source: Phoenix Children's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Phoenix, United States